The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Morgan Stanley reaffirmed their overweight rating on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) in a research report report published on Friday,Benzinga reports. The firm currently ...

Newly acquired product Nurtec ODT/Vydura contributed ... Pfizer terminated its global collaboration with Sangamo for the hemophilia A candidate, giroctocogene fitelparvovec. It will return rights ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

NEW YORK (AP) — Walgreens Boots Alliance says it has agreed to be acquired by the private equity firm Sycamore Partners as the struggling retailer looks to turn itself around after years of ...

Blood clotting disorders can be inherited or acquired. Some types cause excessive bleeding, while others cause excessive ...

Reporting in Washington, I'm Amy Lou. Walgreens Boots Alliance says it has agreed to be acquired by the private equity firm Sycamore Partners as the struggling retailer looks to turn itself around ...

It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for ...

Bass, Berry & Sims is pleased to announce the release of the 13th annual Healthcare Fraud & Abuse Review examining important healthcare fraud developments in 2024. Compiled by the firm's ...